GlobeNewswire

CalibreScientific Acquires BIOZOL Diagnostica, a Leading Independent Distributor of Life Science Products with Extensive Relationships Across Germany

Del

LOS ANGELES, May 14, 2018 (GLOBE NEWSWIRE) -- CalibreScientific is pleased to announce that it has completed the acquisition of BIOZOL Diagnostica Vertrieb GmbH ("BIOZOL" or the "Company"), an independent distributor of life science products across Germany.

Headquartered just outside of Munich, Germany, BIOZOL is one of the largest independent distributors of life science products with a broad offering that spans a variety of innovative suppliers. Its product portfolio of more than 6 million SKUs includes antibodies, proteins, ELISAs, detection kits, biochemicals, reagents and diagnostics kits. Supported by an employee base with deep scientific knowledge, BIOZOL is able to provide a true consultative approach to meet the growing needs of its broad base of customers. This highly diversified client base includes major universities, private and public research institutions, biotechnology, diagnostics and pharmaceutical companies.

"We are excited to add BIOZOL to the CalibreScientific family as its size and scale in Germany presents actionable growth opportunities for the two companies," said Ben Travis, CEO of CalibreScientific. "BIOZOL has built a great reputation in the marketplace over the last 25+ years and we look forward to continuing on that tradition by adding new innovative suppliers to the portfolio to provide a comprehensive solution set with the goal of becoming a single-source provider for our customers."

"This is an exciting time for all of us," stated BIOZOL's Managing Director, Ralf Bäuerle. "The management team at CalibreScientific shared our vision for driving growth over the coming years and we look forward to leveraging their vast experience in the life sciences industry to help elevate BIOZOL to the next level with the goal of enhancing our capabilities in Germany and beyond."

About CalibreScientific Inc.

CalibreScientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics and biopharmaceutical communities. The Company is committed to pushing the boundaries of science and innovation through internal expertise combined with strategic acquisitions that help deliver a differentiated and comprehensive set of products, services and support to our customers. CalibreScientific represents a portfolio of niche life science companies, across various key verticals, that have an unrivaled ability to address the unique challenges of their respective markets. Through a combination of acquisitions and organic growth our global reach extends into over 53 countries, empowering customers all over the world. Headquartered in Los Angeles, California, CalibreScientific continues to grow across a wide array of verticals and geographies, further diversifying its product offering and global footprint to laboratories around the world.

For more information, visit  www.calibrescientific.com , or contact Matthew Lorence, SVP, Marketing,  mclorence@calibrescientific.com .




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CalibreScientific via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma20.2.2019 07:00:00Pressemelding

Combination trial to evaluate safety and anti-tumor activity of agents that target B-cell cancers LAUSANNE, Switzerland, Feb. 20, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been dosed in a Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumor activity of ADCT-402 (loncastuximab tesirine) in combination with Pharmacyclics LLC’s ibrutinib in patients with advanced diffuse large B-cell lymphoma (DLBCL) or mantle cell lymphoma (MCL). ADCT-402, an ADC designed to target and kill CD19-expressing malignant B-cells, is also being evaluated in an ongoing pivotal Phase II clinical trial in patients with relapsed or refractory (R/R) DLBCL and a Phase I clinical trial in combination with IMFINZI® (durvalumab) in patients with multiple types of R/R non-Hodgkin lymphoma. Ibrutinib, a sma

RedAwning Opens Up New Office in Palma de Mallorca, Spain To Offer Industry-Leading Distribution, Marketing + Reservations Services to European Property Managers20.2.2019 02:30:00Pressemelding

New Jetstream Team Office To Support RedAwning Group’s Expansion in Europe and Provide Comprehensive Support For International Clients Emeryville, California, Feb. 19, 2019 (GLOBE NEWSWIRE) -- RedAwning, the world’s largest collection of vacation properties, today announced that it has opened up an office in ParcBit, Palma de Mallorca, Spain to service the RedAwning Group’s growing portfolio of international vacation property managers and to offer RedAwning’s industry-leading distribution, marketing and reservation solutions to managers of alternative accommodations throughout Europe. RedAwning is a single point of entry for managers of single vacation homes and multi-unit boutique hotels, resorts, apart-hotels and corporate apartments to access the widest online travel network in the world, including Booking.com, Expedia, Airbnb, and HomeAway/VRBO, as well as a major travel metasearch sites including trivago, Holidu, HomeToGo and TripAdvisor. RedAwning is also integrated with Google H

STORDIS Joins Open Compute Project as Platinum Member and Announces OCP Global Summit Sponsorship20.2.2019 00:02:00Pressemelding

Austin, TX, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The Open Compute Project Foundation (OCP) announced today that STORDIS, a full-service provider in the field of Open Networking that offers consultancy, system integration, professional support and software development services, has joined as a Platinum member. OCP was initiated in 2011 with a mission to apply the benefits of open source to hardware and rapidly increase the pace of innovation in, near and around the data center and beyond. Since then, OCP has been consistently innovating around open-source contributions, with 200 member companies and thousands of technology leaders and engineers worldwide. STORDIS, an official sponsor of the OCP Global Summit, has built a great reputation and a leading industry network since it was founded in 2007. The company, which is completely dedicated to the idea of Open Networking, counts as one of Europe’s leaders in this emerging technology and is especially known for its knowledge on the P4 progra

Dubai Airports partners with XDubai for one-of-a-kind stunt embodying Dubai’s ambitious spirit19.2.2019 15:46:00Pressemelding

Stunt showcases refreshed DXB brand’s vision of pushing boundaries and creating new experiences DUBAI, United Arab Emirates, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dubai Airports has partnered with action sports brand XDubai to deliver an incredible one-of-a-kind stunt by Emirati athlete and skydiver Mohammed Baker, as part of the new DXB brand which aims to position the world’s busiest international airport as a major destination for culture, hospitality, and entertainment. The stunning showcase, captured in a short film released by both Dubai Airports and XDubai, just following the refreshed brand reveal recently, captures what is believed to be the world’s longest skydive swoop under a fixed structure. As showcased in the video, skydiver Mohammed Baker jumps out of a helicopter with a parachute emblazoned with the new DXB brand, gliding through the Dubai sky before performing one of the world’s longest skydive swoops - measuring 112m - under the Sheikh Zayed Road bridge. With Downtown Du

New PubMatic Research Finds Mobile In-App Monetization Spurred by Video and Header Bidding, Though Challenges Remain19.2.2019 15:00:00Pressemelding

Company releases Q4 2018 QMI report, highlighting key trends in mobile advertising growth REDWOOD CITY, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- PubMatic, the publisher-focused sell-side platform (SSP) for an open digital media future, today released its fourth Quarterly Mobile Index (QMI) of 2018. The report highlights key trends influencing mobile advertising growth, allowing publishers and advertisers to make smarter decisions around their programmatic strategies. Advertisers are increasingly attracted to the enhanced targeting and increased customer engagement of mobile in-app, with many buyers opting for programmatic transaction methods for this inventory (Forrester Consulting). PubMatic’s Q4 2018 QMI Report found that in-app video ad spend was up over 200 percent year-over-year in 2018 as buyers embrace in-stream opportunities. Header bidding technology is also beginning to take hold within the in-app environment, with impression volumes growing more than 300X year-over-year in

Canada Rare Earth Reinvigorates a South American Rare Earth Mine and Processing Opportunity19.2.2019 14:45:00Pressemelding

VANCOUVER, British Columbia, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Canada Rare Earth Corp. (“Canada Rare Earth” or the “Company”) (TSX.V: LL) is pleased to announce that it has re-established discussions and momentum with the owners (the “Owners”) of an advanced prospective rare earth property situated in South America (the “Property”). The recent dialogue has resulted in an agreement outlined in a non-binding letter of intent (the “2019 LOI”) which is significantly different from the original letter of intent announced on October 17, 2017 (the “2017 LOI”). The 2019 LOI is simpler in many regards. For example, under the 2019 LOI Canada Rare Earth will purchase the rare earth concentrate for either sale or further processing onsite, whereas the 2017 LOI provided for more of a joint venture collaboration with joint management and cross ownership of the prospective mine and processing facilities. The 2019 LOI and the 2017 LOI are consistent in that: The Owners will prepare and transport a 50-